Ladder-Like Low Iodine Delivery Rate Injection Protocols Based on BMI at 70 KV by Automated Tube Voltage Selection in Coronary CTA
Table 5
Comparison with the unit of BMI subgroups.
Vessel segment
Group
≤20
20–21
21–22
22–23
23–24
24–25
25–26
Aortic root
Experimental group
537 ± 102
533 ± 89
494 ± 77
525 ± 65
530 ± 81
540 ± 68
504 ± 90
Control group
690 ± 84
618 ± 104
624 ± 89
636 ± 55
624 ± 65
650 ± 89
598 ± 98
t
−5.65
−3.25
−4.45
−6.48
−4.47
−3.88
−3.65
P
0.001
0.004
0.001
0.001
0.001
0.001
0.002
Proximal RCA
Experimental group
485 ± 101
490 ± 84
444 ± 85
471 ± 78
480 ± 90
496 ± 87
448 ± 99
Control group
705 ± 115
628 ± 123
630 ± 82
632 ± 62
651 ± 77
647 ± 84
599 ± 127
t
−6.95
−5.03
−6.59
−8.04
−6.89
−5.09
−6.05
P
0.001
0.001
0.001
0.001
0.001
0.001
0.001
Mid-RCA
Experimental group
444 ± 114
438 ± 83
433 ± 94
441 ± 82
441 ± 93
475 ± 107
410 ± 113
Control group
681 ± 107
603 ± 136
582 ± 106
614 ± 80
629 ± 59
615 ± 83
564 ± 106
t/Z
−6.60
−5.45
−4.80
−6.75
−9.33
−3.80
−3.77a
P
0.001
0.001
0.001
0.001
0.001
0.001
0.001
Distal RCA
Experimental group
395 ± 74
357 ± 75
392 ± 109
398 ± 86
389 ± 80
423 ± 126
380 ± 100
Control group
619 ± 124
565 ± 147
553 ± 130
596 ± 93
575 ± 92
619 ± 94
545 ± 123
t
−7.21
−8.09
−3.80
−6.76
−6.92
−4.61
−5.27
P
0.001
0.001
0.001
0.001
0.001
0.001
0.001
Proximal LAD
Experimental group
506 ± 90
480 ± 90
471 ± 90
491 ± 71
515 ± 84
518 ± 62
458 ± 87
Control group
638 ± 104
585 ± 109
603 ± 86
590 ± 69
593 ± 69
647 ± 95
558 ± 104
t
−4.46
−3.12
−4.10
−5.20
−3.42
−3.48
−3.88
P
0.001
0.006
0.001
0.001
0.003
0.002
0.001
Mid-LAD
Experimental group
444 ± 114
438 ± 83
433 ± 94
441 ± 82
441 ± 93
475 ± 107
410 ± 113
Control group
610 ± 97
552 ± 96
559 ± 77
546 ± 76
557 ± 89
560 ± 102
507 ± 97
t
−5.04
−4.66
−4.76
−4.45
−4.31
−2.32
−3.75
P
0.001
0.001
0.001
0.001
0.001
0.032
0.001
Distal LAD
Experimental group
359 ± 80
345 ± 63
342 ± 91
366 ± 77
362 ± 64
392 ± 73
377 ± 75
Control group
529 ± 97
471 ± 104
455 ± 92
494 ± 63
475 ± 84
484 ± 126
467 ± 74
t/Z
−5.60
−4.75
−3.30a
−5.41
−4.71
−2.68
−4.21
P
0.001
0.001
0.001
0.001
0.001
0.015
0.001
Proximal LCX
Experimental group
483 ± 84
472 ± 76
446 ± 90
482 ± 70
498 ± 91
506 ± 72
464 ± 94
Control group
633 ± 135
565 ± 95
567 ± 88
588 ± 69
582 ± 72
592 ± 95
565 ± 95
t/Z
−4.20
−4.04
−3.89
−5.38
−2.65a
−2.82
−4.00
P
0.001
0.001
0.001
0.001
0.008
0.011
0.001
Distal LCX
Experimental group
393 ± 94
354 ± 64
334 ± 97
382 ± 76
373 ± 64
393 ± 71
374 ± 78
Control group
497 ± 127
477 ± 103
487 ± 90
479 ± 96
493 ± 78
486 ± 76
472 ± 91
t
−2.90
−5.11
−5.14
−3.61
−5.21
−3.39
−4.97
P
0.009
0.001
0.001
0.002
0.001
0.003
0.001
a: using the Wilcoxon rank-sum test. A difference exists in mid-RCA and mid-LAD of the control group. Mid-RCA Dunnett’s T3 test shows that BMI ≤ 20 subgroup differs from the 25 to 26 subgroup ( = 0.026 < 0.05). LSD method shows BMI ≤ 20 subgroup differs from 20 to 21, 22–23, and 25–26 subgroups of mid-LAD ( = 0.045, 0.026, 0.001).